Investment Rating - The investment rating for the company is "Buy" with a maintained outlook [4][15]. Core Views - The report highlights strong growth in e-commerce and product upgrades, particularly for the "Cold Acid Spirit" brand, which shows significant brand momentum [2][6]. - The company achieved a revenue of 840 million yuan in the first half of 2025, representing a year-on-year increase of 19.7%, with a net profit of 85 million yuan, up 17.6% year-on-year [6][8]. - The report anticipates continued growth in net profit for 2025-2027, with expected figures of 200 million yuan, 260 million yuan, and 310 million yuan respectively, reflecting growth rates of 25.8%, 26.5%, and 21.0% [6][8]. Financial Data and Valuation - Projected revenue for 2023A is 1,376 million yuan, with a growth rate of 5%, increasing to 2,485 million yuan by 2027E, with a growth rate of 16% [3][8]. - Net profit is expected to grow from 141 million yuan in 2023A to 310 million yuan in 2027E, with a growth rate of 5% in 2023A and 21% in 2027E [3][8]. - Earnings per share (EPS) is projected to rise from 0.82 yuan in 2023A to 1.80 yuan in 2027E, with a corresponding decrease in price-to-earnings (P/E) ratio from 54.0 to 24.6 over the same period [3][8]. Product and Channel Performance - The company has seen significant growth in its product categories, with adult toothpaste and electric oral care products showing year-on-year increases of 23% and 54.9% respectively in H1 2025 [6][8]. - E-commerce sales have surged by 86.6% in H1 2025, contributing to a 36% share of total sales, indicating a successful channel strategy [6][8]. - The overall gross margin improved to 52.6% in H1 2025, up 5.7 percentage points year-on-year, driven by product upgrades and effective marketing strategies [6][8].
登康口腔（001328）：产品升级电商高增，冷酸灵品牌势能强劲